| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $308K | -1.9% |
| R&D Expense | $400K | -80.0% |
| SG&A Expense | $47.5M | -25.2% |
| Operating Income | -$102.7M | +18.2% |
| Pre-tax Income | -$148.4M | -277.8% |
| Income Tax | -$356K | -135.0% |
| Net Income | -$149.3M | -271.1% |
| EPS (Basic) | -$0.93 | -272.0% |
| EPS (Diluted) | -$0.93 | -272.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.5M | -61.1% |
| Current Assets | $80.1M | -56.8% |
| Total Assets | $159.4M | -45.7% |
| Current Liabilities | $25.0M | +24.0% |
| Long-term Debt | $14.1M | -6.1% |
| Total Liabilities | $42.8M | -12.9% |
| Stockholders' Equity | $116.3M | -52.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.4M | +2.0% |
| Capital Expenditures | $6K | -97.7% |
| Investing Cash Flow | $59.2M | +211.0% |
| Financing Cash Flow | $5.4M | +164.3% |
| Free Cash Flow | -$82.4M | +2.3% |